Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AXS-02 in Knee Osteoarthritis with Bone Marrow Lesions
NCT02746068Phase 3Unknown
- Sponsor
- Axsome Therapeutics, Inc.
- Start
- Mar 2016
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of zoledronic acid in osteoarthritis (OA), sponsored by Axsome Therapeutics, Inc.. Status: unknown.
02
Drugs
zoledronic acid
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02746068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02746068.